-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LAE-005 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LAE-005 in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LAE-005 in Solid Tumor Drug Details: LAE-005 (FAZ-053) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LAE-001 in Hormone-Sensitive Prostate Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LAE-001 in Hormone-Sensitive Prostate Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LAE-001 in Hormone-Sensitive Prostate Cancer Drug Details: LAE-001 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LAE-005 in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LAE-005 in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LAE-005 in Triple-Negative Breast Cancer (TNBC) Drug Details: LAE-005 (FAZ-053)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LAE-001 in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LAE-001 in Metastatic Castration-Resistant Prostate Cancer (mCRPC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.LAE-001 in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Drug Details:LAE-001 is...
-
Product Insights
Kumul Petroleum Hldgs – Lae Floating Storage Regasification and Power Unit – Morobe
Equip yourself with the essential tools needed to make informed and profitable decisions with our Kumul Petroleum Hldgs - Lae Floating Storage Regasification and Power Unit - Morobe report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – LAE-001
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry LAE-001 Drug Details LAE-001 is under development for the treatment of metastatic castration-resistant prostate...
-
Product Insights
Liver Cirrhosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Liver Cirrhosis is scarring of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcohol abuse. The scar tissue damages the normal structure of the liver which affects the normal flow of blood through the liver. Symptoms include loss of appetite, itchy skin, weight loss, tiredness and weakness and nausea. Treatment includes liver transplant surgery. The Liver Cirrhosis - Drugs in Development research report provides a comprehensive overview on the therapeutics under development...